Select your country
Websites worldwide
Select a country to go to the website of the respective STADA sales company.
Australia (2)
Belarus (1)
Belgium (1)
Bosnia-Herzegovina (1)
Croatia (1)
Czech Republic (2)
Denmark (1)
France (1)
Germany (4)
Hungary (1)
Ireland (1)
Italy (1)
Kazakhstan (1)
Lithuania (1)
Montenegro (1)
Netherlands (2)
Poland (1)
Portugal (1)
Romania (1)
Russia (1)
Saudi Arabia (1)
Serbia (1)
Slovakia (1)
Slovenia (1)
Spain (1)
Switzerland (1)
Thailand (1)
The Phillippines (1)
Ukraine (1)
United Arab Emirates (1)
United Kingdom (4)
Many Parkinson’s patients across Europe are missing out on regular specialist advice on treating their condition, according to the findings …
Offers a comprehensive range of presentations to the EU adalimumab
biosimilars market
STADA has taken a significant step towards expanding its Specialty portfolio
Dr Christine Berndt joins STADA from June as Head of Global Development Specialties/Biosimilars
A citrate-free, high-concentration biosimilar to Humira® by resolving European patent dispute with AbbVie
Ignis and STADA’s Britannia sign exclusive licensing agreement to develop and commercialize subcutaneous apomorphine in mainland China, Hong…
STADA is preparing to meet demand for its expanding portfolio by investing almost EUR50 million in a supply-chain hub in Turda, Romania
Experienced expert Erin Federman will oversee commercialization of STADA’s biosimilars portfolio and pipeline